Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe
- PMID: 20218848
- DOI: 10.1586/erv.10.6
Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical